251 related articles for article (PubMed ID: 24211212)
1. AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).
Barauna VG; Mantuan PR; Magalhães FC; Campos LC; Krieger JE
Biochem Biophys Res Commun; 2013 Nov; 441(4):713-9. PubMed ID: 24211212
[TBL] [Abstract][Full Text] [Related]
2. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
Zhao X; Li X; Trusa S; Olson SC
Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
[TBL] [Abstract][Full Text] [Related]
4. Roles of I
Luo Y; Zhang Q; Ding J; Yu M; Jiang J; Yang F; Wang S; Wang A; Wang L; Wu S; Xia Y; Lu D
Biochem Biophys Res Commun; 2019 Aug; 516(3):613-618. PubMed ID: 31239152
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
[TBL] [Abstract][Full Text] [Related]
6. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
[TBL] [Abstract][Full Text] [Related]
7. Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway.
Chao Y; Ye P; Zhu L; Kong X; Qu X; Zhang J; Luo J; Yang H; Chen S
J Cell Physiol; 2018 Feb; 233(2):1384-1395. PubMed ID: 28518223
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
9. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
10. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
Matsumoto S; Shimabukuro M; Fukuda D; Soeki T; Yamakawa K; Masuzaki H; Sata M
Cardiovasc Diabetol; 2014 Jan; 13():30. PubMed ID: 24485356
[TBL] [Abstract][Full Text] [Related]
11. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
13. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.
Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC
Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287
[TBL] [Abstract][Full Text] [Related]
14. Far-infrared radiation acutely increases nitric oxide production by increasing Ca(2+) mobilization and Ca(2+)/calmodulin-dependent protein kinase II-mediated phosphorylation of endothelial nitric oxide synthase at serine 1179.
Park JH; Lee S; Cho DH; Park YM; Kang DH; Jo I
Biochem Biophys Res Commun; 2013 Jul; 436(4):601-6. PubMed ID: 23756809
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.
Mason RP; Jacob RF; Kubant R; Jacoby A; Louka F; Corbalan JJ; Malinski T
Br J Clin Pharmacol; 2012 Jul; 74(1):141-6. PubMed ID: 22283728
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Biol Reprod; 2004 Mar; 70(3):785-96. PubMed ID: 14627548
[TBL] [Abstract][Full Text] [Related]
17. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells.
Kataoka H; Murakami R; Numaguchi Y; Okumura K; Murohara T
Eur J Pharmacol; 2010 Jun; 636(1-3):36-41. PubMed ID: 20353766
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs.
Presta I; Tassone EJ; Andreozzi F; Perticone M; Sciacqua A; Laino I; Musca D; Martino F; Sesti G; Perticone F
Atherosclerosis; 2011 Dec; 219(2):463-7. PubMed ID: 21937042
[TBL] [Abstract][Full Text] [Related]
20. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
